atai Life Sciences to Announce Second Quarter 2022 Financial Results and Business Update
01 August 2022 - 8:59PM
atai Life Sciences N.V. (Nasdaq: ATAI) (“atai”), a clinical-stage
biopharmaceutical company aiming to transform the treatment of
mental health disorders, plans to announce its second quarter 2022
financial results and business update on Monday, August 15, 2022.
A video interview with atai management will be available at 8:30
a.m. (ET) at https://vimeo.com/atailifesciences. The archived video
interview will be available in the “Events” section of the atai
website at https://www.atai.life/.
About atai Life Sciences atai Life Sciences is
a clinical-stage biopharmaceutical company aiming to transform the
treatment of mental health disorders. Founded in 2018 as a response
to the significant unmet need and lack of innovation in the mental
health treatment landscape, atai is dedicated to acquiring,
incubating, and efficiently developing innovative therapeutics to
treat depression, anxiety, addiction, and other mental health
disorders.
atai's business model combines funding, technology, scientific,
and regulatory expertise with a focus on innovative compounds,
including psychedelic therapy and other drugs with differentiated
safety profiles and therapeutic potential. By pooling resources and
best practices, atai aims to responsibly accelerate the development
of new medicines across its companies to achieve clinically
meaningful and sustained behavioral change in mental health
patients.
atai's vision is to heal mental health disorders so that
everyone, everywhere can live a more fulfilled life. For more
information, please visit https://www.atai.life/.
Contact Information
Investor Contact:Greg WeaverChief Financial Officer
Email: IR@atai.life
Media Contact:Allan Malievsky Senior Director, External
AffairsEmail: allan@atai.life
ATAI Life Sciences NV (NASDAQ:ATAI)
Historical Stock Chart
From Mar 2024 to Apr 2024
ATAI Life Sciences NV (NASDAQ:ATAI)
Historical Stock Chart
From Apr 2023 to Apr 2024